Emerging data suggest this peptide, a dual agonist targeting both GLP-1 and another hormone, may provide a notable step forward for weight management . Preliminary patient trials have shown considerable losses in abdominal mass , possibly outperforming other weight-loss medications . Nevertheless , further study is necessary to thoroughly understan